B-cell biomarkers such as CD19, CD20, CD22, CD79a and PAX-5 that play an important role in immunophenotypic expression patterns of DLBCL and flow cytometry have shown surface immunoglobulin light chain restriction in a majority of cases (Table 2) [34,92]. This evidence concerns the gene PAX5 and diffuse large B-cell lymphoma.